Constitutive and inducible in vivo protein-DNA interactions at the tumor necrosis factor-α promoter in primary human T lymphocytes

Gene Expression

Volumn 8, Issue 2, 1999, Pages 115-127

  Becker, Christoph ^a   Barbulescu, Karina ^a   Wirtz, Stefan ^a   Zum Büschenfelde, Karl Hermann Meyer ^a   Pettersson, Sven ^b   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AFT 2 c jun; In vivo footprinting; Promoter; SP1 Egr; TNF

Indexed keywords

CD4 ANTIGEN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BINDING SITE; DNA PROTEIN COMPLEX; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; DNA; DNA FOOTPRINTING; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032752796     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Barbulescu, K.; Becker, C; Schlaak, J. F.; Schmitt, E.; Meyer-zum-Buschenfelde, K.-H.; Neurath, M. F. IL-12 and IL-18 differentially activate the human IFNgamma promoter in primary CD4+ T lymphocytes. J. Immunol. 160: 3642-3649; 1998.
2. Barbulescu, K.; Meyer-zum-Buschenfelde, K.-H.; Neurath, M. F. Constitutive and inducible protein/ DNA interactions of the interferon-gamma promoter in vivo in CD45RA and CD45RO T helper subsets. Eur. J. Immunol. 27: 1098-1108; 1997.
3. Campbell, I. L.; Iscaro, A.; Harrison, K. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141: 2325-2329; 1988.
4. Collart, M. A.; Belin, D.; Vassalli, J. D.; de-Kossodo, K. S.; Vassalli, P. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachec-tin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113-2118; 1986.
5. Di, G. N.; Visvanathan, K.; Lloyd, A.; Wakefield, D. Expression of TNF-alpha by human plasma cell in chronic inflammation. J. Leukoc. Biol. 61: 667-678; 1997.
6. Economou, J. S.; Rhoades, K.; Essner, R.; McBride, W. H.; Gasson, J. C.; Morton, D. L. Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170: 321-326; 1989.
7. Fong, C. L.; Siddiqui, A. H.; Mark, D. F. Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene. Nucleic Acids Res. 22: 1108-1114; 1994.
8. Garrity, P. A.; Chen, D.; Rothenberg, E. V.; Wold, B. J. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 14: 2159-2169; 1994.
9. Garrity, P. A.; Wold, B. J. Effects of different DNA polymerases in ligation-mediated PCR: Enhanced genomic sequencing and in vivo footprinting. Proc. Natl. Acad. Sei. USA 89: 1021-1025; 1992.
10. Goldfeld, A. E.; Doyle, C; Maniatis, T. Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sei. USA 87: 9769-9773; 1990.
11. Goldfeld, A. E.; McCaffrey, P. G.; Strominger, J. L.; Rao, A. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J. Exp. Med. 178: 1365-1379; 1993.
12. Goldfeld, A. E.; Strominger, J. L.; Doyle, C. Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J. Exp. Med. 174: 73-81; 1991.
13. Goodwin, R. G.; Anderson, D.; Jerzy, R.; Davis, T.; Brannan, C. L; Copeland, N. G.; Jenkins, N. A.; Smith, C. A. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol. Cell. Biol. 11: 3020-3026; 1991.
14. Han, J.; Huez, G.; Beutler, B. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J. Immunol. 146: 1843-1848; 1991.
15. Han, J. H.; Beutler, B.; Huez, G. Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages. Biochim. Biophys. Acta 1090: 22-28; 1991.
16. Hofman, F. M.; Hinton, D. R.; Johnson, K.; Merrill, J. E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170: 607-612; 1989.
17. Keffer, J.; Probert, L.; Cazlaris, H.; Georgopoulos, S.; Kaslaris, E.; Kioussis, D.; Kollias, G. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J. 10: 4025-4031; 1991.
18. Kettelhut, I. C.; Fiers, W.; Goldberg, A. L. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc. Natl. Acad. Sei. USA 84: 4273-4277; 1987.
19. Kramer, B.; Meichle, A.; Hensel, G.; Charnay, P.; Kronke, M. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim. Biophys. Acta 1219: 413-421; 1994.
20. Kramer, B.; Wiegmann, K.; Kronke, M. Regulation of the human TNF promoter by the transcription factor Ets. J. Biol. Chem. 270: 6577-6583; 1995.
21. Loetscher, H.; Pan, J. Y.; Lahm, H. W.; Gentz, R.; Brockhaus, M.; Tabuchi, H.; Lesslauer, W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61: 351-359; 1990.
22. Mueller, P. R.; Wold, B. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246: 780-786; 1989.
23. Neurath, M. F.; Meyer-zum-Büschenfelde, K.-H. Protective and pathogenic roles of cytokines in inflammatory bowel diseases. J. Invest. Med. 44:516-523; 1996.
24. Neurath, M. F.; Pettersson, S.; Meyer-zum-Büschenfelde, K.-H.; Strober, W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2: 998-1003; 1996.
25. Nordeen, S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6: 454-158; 1988.
26. Pasparakis, M.; Alexopoulou, L.; Episkopou, V.; Kollias, G. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411; 1996.
27. Pope, R. M.; Leutz, A.; Ness, S. A. C/EBP beta regulation of the tumor necrosis factor alpha gene. J. Clin. Invest. 94: 1449-1455; 1994.
28. Probert, L.; Akassoglou, K.; Alexopoulou, L.; Douni, E. Haralambous, S.; Hill, S.; Kassiotis, G.; Kontoyiannis, D.; Pasparakis, M.; Plows, D.; Kollias, G. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J. Leukoc. Biol. 59: 518-525; 1996.
29. Rhoades, K. L.; Golub, S. H.; Economou, J. S. The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 267: 22102-2217; 1992.
30. Schall, T. J.; Lewis, M.; Koller, K. J.; Lee, A.; Rice, G. C.; Wong, G. H.; Gatanaga, T.; Granger, G. A.; Lentz, R.; Raab, H. et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61: 361-370; 1990.
31. Schattner, A. Lymphokines in autoimmunity-a critical review. Clin. Immunol. Immunopathol. 70: 177-189; 1994.
32. Schreiber, E.; Matthias, P.; Muller, M. M.; Schaffner, W. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17: 6419; 1989.
33. Smith, C. A.; Davis, T.; Anderson, D.; Solam, L.; Beckmann, M. P.; Jerzy, R.; Dower, S. K.; Cosman, D.; Goodwin, R. G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019-1023; 1990.
34. Steffen, M.; Ottmann, O. G.; Moore, M. A. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL2 and anti-T3. J. Immunol. 140: 2621-2624; 1988.
35. Sung, S. S.; Bjomdahl, J. M.; Wang, C. Y.; Kao, H. T.; Fu, S. M. Production of tumor necrosis factor/ cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J. Exp. Med. 167: 937-953; 1988.
36. Sung, S. S.; Jung, L. K.; Walters, J. A.; Chen, W.; Wang, C. Y.; Fu, S. M. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med. 168: 1539-1551; 1988.
37. Takashiba, S.; Shapira, L.; Amar, S.; Van, D. T. Clon-ing and characterization of the human TNF alpha promoter region. Gene 131: 307-308; 1993.
38. Tracey, K. J.; Fong, Y.; Hesse, D. G.; Manogue, K. R.; Lee, A. T.; Kuo, G. C.; Lowry, S. F.; Cerami, A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664; 1987.
39. Tracey, K. J.; Wei, H.; Manogue, K. R.; Fong, Y.; Hesse, D. G.; Nguyen, H. T.; Kuo, G. C.; Beutler, B.; Cotran, R. S.; Cerami, A. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167: 1211-1227; 1988.
40. Tsai, E. Y.; Jain, J.; Pesavento, P. A.; Rao, A.; Goldfeld, A. E. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol. Cell. Biol. 16:459-467; 1996.
41. Tsai, E. Y.; Yie, J.; Thanos, D.; Goldfeld, A. E. Celltype specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol. Cell. Biol. 16: 5232-5244; 1996.